CPHI 2026 – 23/07/2026
PCI Drug-Device 28/05/2026

Current Edition

ramusmedical
Europe

CPhI Worldwide opens entries for largest ever Pharma Awards

The 2017 awards include 8 new categories - celebrating outstanding achievements in the pharma industry Full list of categories: Excellence in Pharma: API Developme...
Continue Reading →
Europe

Onxeo Announces Positive Preclinical Proof of Concept Results Confirming AsiDNA™ Activity via Systemic Administration

Paris (France) -  Onxeo S.A., a clinical-stage biotechnology company specializing in the development of innovative drugs for the treatment of orphan diseases, in part...
Continue Reading →
Europe

SERIALISATION IMPROVES PUBLIC HEALTH

All pharmaceutical companies selling drugs in the US must be partially compliant with the FDA serialisation regulations since January 2015. And since the beginning of...
Continue Reading →
Europe

Zebinix (eslicarbazepine acetate) Data Demonstrate No Significant Negative Consequences on Neurocognitive Function in Children with Focal Epilepsy

Eslicarbazepine acetate was shown not to have a significant negative consequence on attention, information processing and working memory; in addition it was shown to ...
Continue Reading →
Europe

Genkyotex Initiates Patient Enrollment into Phase 2 Trial of GKT831 in Primary Biliary Cholangitis

Genkyotex, a biopharmaceutical company and the leader in NOX therapies, announced today that it has begun enrolling patients into the Company's Phase 2 clinical trial...
Continue Reading →
Europe

WideCells Group PLC CellPlan – Revenue with launch of first UK insurance product for stem cell treatment

WideCells Group PLC, the healthcare services company focused on providing stem cell services and ground breaking insurance for stem cell treatment, is delighted to an...
Continue Reading →
Europe

Mobile health (mHealth) increasingly popular as shift towards value-based medicine continues, says GBI Research

The uptake of mobile health (mHealth), which is used worldwide to deliver a range of healthcare services, including data collection and remote patient monitoring, wil...
Continue Reading →
Australasia

MDxHealth and Queensland University of Technology Collaborate on Oral Cancer Liquid Biopsy Test

RVINE, CA, and HERSTAL, BELGIUM - MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed a scientific agreement with QUT bluebox, the commercialization ...
Continue Reading →
Europe

Quotient and Ortho Clinical Diagnostics to Present Symposium on Role of Extended Phenotyping in Blood Matching at ISBT

EYSINS, Switzerland and RARITAN, N.J. – Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, and Ortho Clinical Diagnostics (“Ortho”), a global lea...
Continue Reading →
news

Tresiba® demonstrated no increased risk of major cardiovascular events and significant reduction in rates of severe hypoglycaemia compared to insulin glargine U100 in the DEVOTE trial

San Diego, US ­- Novo Nordisk today announced the primary results from DEVOTE - the first randomised, double-blind, treat-to-target, event-driven trial comparing two ...
Continue Reading →
Quotient
CPHI 2026 – 20/07/2026